Literature DB >> 2890019

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

J G Coghlan1, D Gilligan, H Humphries, D McKenna, C Dooley, E Sweeney, C Keane, C O'Morain.   

Abstract

In 39 patients with endoscopically healed duodenal ulcers repeat endoscopy and two antral biopsies after 1 year showed a relapse rate of 59%. Only post-treatment Campylobacter pylori status was a significant predictor of endoscopic relapse. 79% of patients who remained culture positive had a relapse, compared with 27% of culture-negative patients. Relapse was more likely (66%) in patients with a recurrence of C pylori after apparent eradication of the organism than in those who remained negative for C pylori (10%). No patient who remained negative for C pylori had histological gastritis, whereas all with recurrence of C pylori showed histological gastritis. These findings suggest an important role for C pylori in duodenal ulcer relapse in the year after treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890019     DOI: 10.1016/s0140-6736(87)91545-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  123 in total

1.  Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study.

Authors:  S K Lam; C K Ching; K C Lai; B C Wong; C L Lai; C K Chan; L Ong
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Role of Helicobacter pylori in duodenal ulcer.

Authors:  E A Rauws
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

3.  Gastric urease and peptic ulcer disease in Ireland in the 1940s--the Fitzgerald connection.

Authors:  H J O'Connor; M J M Buckley; C A O'Morain
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

Review 4.  Helicobacter pylori.

Authors:  B Drumm
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

5.  Transport conditions and number of biopsies necessary for culture of Helicobacter pylori.

Authors:  M Kjøller; A Fischer; T Justesen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

6.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

Review 7.  How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.

Authors:  David Y Graham; Sun-Young Lee
Journal:  Gastroenterol Clin North Am       Date:  2015-06-19       Impact factor: 3.806

Review 8.  Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.

Authors:  F Mégraud; H Lamouliatte
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

Review 9.  Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.

Authors:  B C Delaney
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

10.  Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.

Authors:  J T Smith; R E Pounder; C U Nwokolo; S Lanzon-Miller; D G Evans; D Y Graham; D J Evans
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.